Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High prevalence of hepatitis B and HIV among women survivors of sexual violence in South Kivu province, eastern Democratic Republic of Congo

Parvine Basimane Bisimwa, Dieudonné Bihehe Masemo, Aline Kusinza Byabene, Georges Kikuni Besulani, Théophile Kashosi Mitima, Cadeau Mugisho Matabishi, Bienfait Mitima Misuka, View ORCID ProfileOmari Mukanga, Jean Paulin Mukonkole, Jean Bisimwa Nachega, Denis Mukwege, View ORCID ProfileKomas Narcisse Patrice Joseph
doi: https://doi.org/10.1101/2023.09.22.23295978
Parvine Basimane Bisimwa
1Viral Hepatitis Laboratory, Institut Pasteur de Bangui, PO Box 923, Bangui, Central African Republic
2Faculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo
3Departments of Internal Medicine, Panzi Hôpital General Referral Hospital, Bukavu, Democratic Republic of Congo
4Molecular Biology Laboratory, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo
5International Center Advanced for Research and Training (ICART)/Panzi Fondation, Bukavu, Democratic Republic of Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dieudonné Bihehe Masemo
2Faculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo
3Departments of Internal Medicine, Panzi Hôpital General Referral Hospital, Bukavu, Democratic Republic of Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aline Kusinza Byabene
2Faculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo
3Departments of Internal Medicine, Panzi Hôpital General Referral Hospital, Bukavu, Democratic Republic of Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georges Kikuni Besulani
2Faculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo
3Departments of Internal Medicine, Panzi Hôpital General Referral Hospital, Bukavu, Democratic Republic of Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Théophile Kashosi Mitima
4Molecular Biology Laboratory, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cadeau Mugisho Matabishi
3Departments of Internal Medicine, Panzi Hôpital General Referral Hospital, Bukavu, Democratic Republic of Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bienfait Mitima Misuka
4Molecular Biology Laboratory, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omari Mukanga
6Statistical Service, VVS-Panzi General Referral Hospital, Bukavu, Democratic Republic of Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Omari Mukanga
Jean Paulin Mukonkole
2Faculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo
3Departments of Internal Medicine, Panzi Hôpital General Referral Hospital, Bukavu, Democratic Republic of Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Bisimwa Nachega
7Departments of Epidemiology, Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA
8Departments of Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
9Department of Medicine, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Mukwege
2Faculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo
5International Center Advanced for Research and Training (ICART)/Panzi Fondation, Bukavu, Democratic Republic of Congo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Komas Narcisse Patrice Joseph
1Viral Hepatitis Laboratory, Institut Pasteur de Bangui, PO Box 923, Bangui, Central African Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Komas Narcisse Patrice Joseph
  • For correspondence: npkomas{at}yahoo.fr narcisse.komas{at}pasteur-bangui.cf
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Limited data are available on the prevalence rates of hepatitis B and acquired immunodeficiency syndrome (AIDS) among women survivors of sexual violence (WSSV) in South Kivu province, in the eastern part of the Democratic Republic of Congo (DRC), where armed conflicts persist. Here, we aimed to assess the prevalence of these two diseases in this vulnerable local population.

Methods A total of 1002 WSSV, aged from 18 to 70 years old were enrolled from May 2018 to May 2020 at three one-stop centers, set up at the Panzi, Mulamba and Bulenga hospitals. Blood samples were collected and tested for hepatitis B virus (HBV) and human immunodeficiency virus (HIV) antigens and antibodies using enzyme-linked immunoassay (ELISA) methods. Viral load quantification for HBV and HIV were performed using the GeneXpert.

Results For HBV, overall prevalence was 8.9% (95% CI [7.2–10.8%]), 32.1% [29.3–35.0%], and 14.5% [12.3–16.8%] for HBsAg, anti-HBc and anti-HBs antibodies, respectively. Among the 89 HBsAg-positive patients, 17 (19.1%) were HBeAg-positive. The mean age was 40.57±14.99 years in the HBsAg-positive group (p=0.025). Risk factors for HBV infection were age (≥35 years) (AOR=1.83 [1.02-3.32]; p=0.041), having no schooling (AOR=4.14 [1.35-12.62]; p=0.012) or only primary school-level (AOR=4.88 [1.61-14.75]; p=0.005), and multiple aggressors (AOR=1.76 [1.09-2.84], p=0.019). The prevalence of HIV was 4.3% [3.1–5.7%]. HIV/HBV co-infection occurred only in 5 individuals (0.5%). The HBV viral load was detectable (>2,000 copies/mL) in 61.8% of HBsAg-positive subjects and 64.8% HIV-positive subjects had a high viral load (>1,000 copies/mL).

Conclusion This study revealed a high prevalence of HBV and HIV infections among WSSV in South Kivu. These results highlight the urgent need for systematic screening of HBV and HIV by integrating fourth-generation ELISA tests in HIV and HBV control programs.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

PBB received partial financial support from the World Bank for her PhD thesis through the Panzi Foundation (grant number IDA H 980-ZR). NO: the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study obtained approval from the ethics committee of the Catholic University of Bukavu (UCB/CIE/NC/008/2016) reviewed in 2019 by the national health ethics committee (CNES001/DPSK/124PP/2019) and from the ethics and scientific committees of the University de Bangui (22/UB/FACSS/CSVPR/19). Written informed consent was signed by the participant in the interest of knowing her serological status to consider early treatment in case of a positive result, as well as for her participation in the study. The preliminary results for HBV and HIV screening were given to participants immediately after screening and 3 weeks later for definitive result. HIV- and HBV-positive cases were referred to the Panzi Hospital for medical care.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data were encoded and stored in an electronic database. Follow-up sheets were securely stored at the ICART/Panzi Foundation Research Center and accessible only to the principal investigator of the study, Dr Parvine Basimane Bisimwa. These data include epidemiological, clinical and therapeutic data. As these data are anonymized for the protection of participants according to the health ethics guidelines of our region, we cannot make them available to third parties. Nevertheless, all these data are available from Parvine Bisimane Bisimwa at: parvinebisimwa{at}gmail.com

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted September 25, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High prevalence of hepatitis B and HIV among women survivors of sexual violence in South Kivu province, eastern Democratic Republic of Congo
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High prevalence of hepatitis B and HIV among women survivors of sexual violence in South Kivu province, eastern Democratic Republic of Congo
Parvine Basimane Bisimwa, Dieudonné Bihehe Masemo, Aline Kusinza Byabene, Georges Kikuni Besulani, Théophile Kashosi Mitima, Cadeau Mugisho Matabishi, Bienfait Mitima Misuka, Omari Mukanga, Jean Paulin Mukonkole, Jean Bisimwa Nachega, Denis Mukwege, Komas Narcisse Patrice Joseph
medRxiv 2023.09.22.23295978; doi: https://doi.org/10.1101/2023.09.22.23295978
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
High prevalence of hepatitis B and HIV among women survivors of sexual violence in South Kivu province, eastern Democratic Republic of Congo
Parvine Basimane Bisimwa, Dieudonné Bihehe Masemo, Aline Kusinza Byabene, Georges Kikuni Besulani, Théophile Kashosi Mitima, Cadeau Mugisho Matabishi, Bienfait Mitima Misuka, Omari Mukanga, Jean Paulin Mukonkole, Jean Bisimwa Nachega, Denis Mukwege, Komas Narcisse Patrice Joseph
medRxiv 2023.09.22.23295978; doi: https://doi.org/10.1101/2023.09.22.23295978

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)